Apex Capital Management’s Celgene Corp CELG Stock Holding History

Apex Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$4.31M	Sell	43,048 -5,090	-11%	-$524K	0.1%	157
2015 Q4	$5.76M	Buy	48,138 +926	+2%	+$107K	0.13%	144
2015 Q3	$5.11M	Sell	47,212 -4,298	-8%	-$533K	0.12%	144
2015 Q2	$5.96M	Sell	51,510 -1,899	-4%	-$217K	0.13%	136
2015 Q1	$6.16M	Sell	53,409 -4,335	-8%	-$518K	0.15%	132
2014 Q4	$6.46M	Sell	57,744 -387	-0.7%	-$40.8K	0.17%	110
2014 Q3	$5.51M	Buy	58,131 +1,295	+2%	+$117K	0.17%	100
2014 Q2	$4.88M	Sell	56,836 -1,874	-3%	-$143K	0.15%	107
2014 Q1	$4.1M	Buy	58,710 +944	+2%	+$74.8K	0.14%	121
2013 Q4	$4.88M	Sell	57,766 -4,472	-7%	-$354K	0.18%	96
2013 Q3	$4.79M	Sell	62,238 -17,360	-22%	-$1.22M	0.21%	89
2013 Q2	$4.65M	Buy	+79,598	New	+$4.79M	0.23%	104

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Apex Capital Management's CELG Position: Q1 2016 in Review

Apex Capital Management reduced its Celgene Corp (CELG) stake by 11% in Q1 2016, selling an estimated $524K and leaving 43,048 shares worth $4.31M. The position accounts for 0.1% of the portfolio, ranked #157.

Apex Capital Management first reported a position in CELG in Q2 2013 and has held it in 12 quarters since. The position peaked at $6.46M in Q4 2014. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

Apex Capital Management held 43,048 shares of Celgene Corp worth $4.31M as of Q1 2016.
Apex Capital Management sold 5,090 Celgene Corp shares in Q1 2016, an estimated $524K.
Celgene Corp made up 0.1% of Apex Capital Management's portfolio in Q1 2016, its #157 holding.
Apex Capital Management first reported a position in Celgene Corp in Q2 2013 and has held it in 12 quarters since.
Apex Capital Management's Celgene Corp position peaked at $6.46M in Q4 2014.
1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.